Entity Common Stock, Shares Outstanding of T2 Biosystems, Inc. from 12 Sep 2014 to 11 Nov 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
T2 Biosystems, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Sep 2014 to 11 Nov 2024.
  • T2 Biosystems, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2024 was 21,042,952, a 420% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

T2 Biosystems, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 21,042,952 +16,992,658 +420% 11 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 17,479,954 -316,100,056 -95% 05 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 5,512,332 -14,763,096 -73% 28 Mar 2024 10-K 01 Apr 2024 2023 FY
Q3 2023 4,050,294 -3,268,811 -45% 10 Nov 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 333,580,010 -18,962,718 -5.4% 04 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 20,275,428 -150,761,564 -88% 27 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 7,319,105 -158,648,819 -96% 08 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 352,542,728 +186,696,985 +113% 11 Aug 2022 10-Q 16 Aug 2022 2022 Q2
Q1 2022 171,036,992 +22,545,319 +15% 18 Mar 2022 10-K 23 Mar 2022 2021 FY
Q3 2021 165,967,924 +18,012,393 +12% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 165,845,743 +17,896,441 +12% 06 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 148,491,673 +47,738,809 +47% 26 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 147,955,531 +101,276,368 +217% 03 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 147,949,302 +103,413,730 +232% 06 Aug 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 100,752,864 +56,432,816 +127% 13 Mar 2020 10-K 16 Mar 2020 2019 FY
Q3 2019 46,679,163 +2,640,409 +6% 14 Nov 2019 10-Q 18 Nov 2019 2019 Q3
Q2 2019 44,535,572 +767,927 +1.8% 25 Jul 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 44,320,048 +8,300,248 +23% 08 Mar 2019 10-K 14 Mar 2019 2018 FY
Q3 2018 44,038,754 +8,213,794 +23% 30 Oct 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 43,767,645 +13,003,326 +42% 31 Jul 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 36,019,800 +5,425,458 +18% 14 Mar 2018 10-K 19 Mar 2018 2017 FY
Q3 2017 35,824,960 +5,393,659 +18% 30 Oct 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 30,764,319 +6,399,576 +26% 02 Aug 2017 10-Q 04 Aug 2017 2017 Q2
Q1 2017 30,594,342 +6,345,483 +26% 28 Apr 2017 10-Q 08 May 2017 2017 Q1
Q3 2016 30,431,301 +10,046,769 +49% 07 Nov 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 24,364,743 +4,040,002 +20% 04 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 24,248,859 +4,123,224 +20% 04 Mar 2016 10-K 09 Mar 2016 2015 FY
Q3 2015 20,384,532 +343,928 +1.7% 03 Nov 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 20,324,741 03 Aug 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 20,125,635 02 Mar 2015 10-K 04 Mar 2015 2014 FY
Q3 2014 20,040,604 12 Sep 2014 10-Q 19 Sep 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.